NCT00909896

Brief Summary

This study is being done to evaluate the efficacy of robotic approach for staging of endometrial cancer as compared to an equivalent abdominal approach. The primary objective is to measure and compare postoperative pain at rest at several time points between two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 8, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 29, 2009

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2013

Completed
Last Updated

April 2, 2018

Status Verified

March 1, 2018

Enrollment Period

3.8 years

First QC Date

May 28, 2009

Last Update Submit

March 30, 2018

Conditions

Keywords

endometrialpain

Outcome Measures

Primary Outcomes (1)

  • The outcome measure is mean difference in post operative pain VAS scores reported by subjects at rest at the several time points between two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer.

    up to 24 hours

Secondary Outcomes (1)

  • Secondary outcomes will include the measurement of post operative pain after leg extension, post operative quality of life, post operative opioid requirements during first 24hours, survival status up to five years.

    up to 5 years

Study Arms (2)

Robotic Surgery candidates

Group of patients receive Robotic approach for endometrial cancer staging

Open Laparotomy Surgical Candidates

Patients receiving open laparotomy for endometrial cancer surgical staging

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female subjects ages 18-85 years old, Pre operative diagnosis of clinical stage I or II endometrial cancer, Subject able to tolerate use of opioids for pain management, Eastern Cooperative Oncology Group (ECOG)0-3.

You may qualify if:

  • Female subjects between ages 18-86 years old
  • Subject provided written consent
  • Preoperative diagnosis of stage i or II endometrial cancer
  • Subject scheduled to undergo robotic hysterectomy or open abdominal hysterectomy at The Ohio State University
  • Subject should be expected to be able to use and tolerate opioids for pain management
  • Pre operative health is graded as ASA I-III
  • ECOG(Eastern Cooperative Oncology Group)Performance status 0-3
  • Subject willing to comply with scheduled visits

You may not qualify if:

  • Subject is prisoner, pregnant, or under age 18 or over age 85
  • Hypersensitivity to opioids
  • subject is breastfeeding
  • Preoperative Health grade ASA IV-V
  • ECOG Performance Status 4-5
  • History of receiving prior chemotherapy or radiation therapy
  • Subject schedule for additional procedures at the same time as the surgical staging
  • Subject with pain related illness that to the PI discretion would interfere with study assessments.
  • Known history of alcohol, analgesic, or narcotic abuse within 12 months.
  • Subjects taking NSAID(nonsteroidal anti inflammatory drug medications)within 7 days prior to baseline visit.
  • Require and/or receive chronic analgesic therapy for any pain related condition
  • Severe acute or chronic medical or psychiatric condition that would interfere with the study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Related Links

MeSH Terms

Conditions

Endometrial NeoplasmsPain

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • David Cohn, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 28, 2009

First Posted

May 29, 2009

Study Start

April 8, 2009

Primary Completion

January 29, 2013

Study Completion

January 29, 2013

Last Updated

April 2, 2018

Record last verified: 2018-03

Locations